Form 4: Hartford CFO Beth Ann Costello Receives New Stock Options
Insider Transaction Report
Hartford Insurance Group's EVP and CFO, Beth Ann Costello, reported the acquisition of 22,051 new stock options and updated her beneficial ownership of common stock and existing derivative securities.
Summary
- Beth Ann Costello, Executive Vice President and Chief Financial Officer of Hartford Insurance Group, Inc. (HIG), reported changes in her beneficial ownership.
- Acquired 22,051 stock options with an exercise price of $140.54, granted on February 24, 2026, and expiring on February 24, 2036.
- These newly acquired options will vest in three equal annual installments, with one-third becoming exercisable on February 24, 2027, an additional one-third on February 24, 2028, and the final one-third on February 24, 2029.
- Beneficially owns 92,988.282 shares of Common Stock directly.
- Holds a total of 479,602 derivative securities (stock options) across various grants with exercise prices ranging from $49.01 to $140.54 and expiration dates extending to February 24, 2036.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive disclosure, reflecting a routine grant of stock options to a key executive, which aligns management's interests with shareholders. It is a standard compensation event rather than a significant operational or financial announcement.
Positives
- The acquisition of 22,051 new stock options aligns the executive's long-term incentives with shareholder value creation.
- The continued grant of equity compensation to a key executive demonstrates ongoing commitment to retaining and motivating senior leadership.
Future Outlook
The future outlook for the reporting person's equity compensation includes the vesting of 22,051 newly granted stock options in equal installments on February 24, 2027, February 24, 2028, and February 24, 2029. Additionally, portions of other existing option grants will continue to vest on February 27, 2026, February 28, 2026, February 25, 2027, and February 27, 2027.
Industry Context
StockSavvy.ai notes that executive stock option grants are a common component of compensation packages in the insurance industry, aligning management incentives with shareholder value. This routine disclosure reflects standard corporate governance practices for executive compensation.
Stakeholder Impact
- Shareholders: The grant of stock options to a key executive helps align management's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term stock performance.
Next Steps
- Vesting of 22,051 new stock options in three annual installments starting February 24, 2027.
- Continued vesting of previously granted stock options according to their respective schedules.
Key Dates
| Date | Description |
|---|---|
| 02/27/2021 | Stock options with an exercise price of $53.81 became fully exercisable. |
| 02/26/2022 | Stock options with an exercise price of $49.01 became fully exercisable. |
| 02/25/2023 | Stock options with an exercise price of $55.27 became fully exercisable. |
| 02/23/2024 | Stock options with an exercise price of $51.87 became fully exercisable. |
| 02/28/2024 | One-third of stock options with an exercise price of $78.28 became exercisable. |
| 02/23/2025 | Stock options with an exercise price of $69.41 became fully exercisable. |
| 02/27/2025 | One-third of stock options with an exercise price of $95.74 became exercisable. |
| 02/28/2025 | An additional one-third of stock options with an exercise price of $78.28 became exercisable. |
| 02/24/2026 | Earliest transaction date; grant date for 22,051 new stock options. |
| 02/25/2026 | One-third of stock options with an exercise price of $116.41 became exercisable. |
| 02/26/2026 | Signature date of the reporting person's attorney-in-fact. |
| 02/27/2026 | An additional one-third of stock options with an exercise price of $95.74 will become exercisable. |
| 02/28/2026 | The remaining one-third of stock options with an exercise price of $78.28 will become exercisable. |
| 02/24/2027 | One-third of the newly granted stock options (exercise price $140.54) will become exercisable. |
| 02/25/2027 | An additional one-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/27/2027 | The remaining one-third of stock options with an exercise price of $95.74 will become exercisable. |
| 02/24/2028 | An additional one-third of the newly granted stock options (exercise price $140.54) will become exercisable. |
| 02/25/2028 | The remaining one-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/27/2028 | Expiration date for stock options with an exercise price of $53.81. |
| 02/24/2029 | The remaining one-third of the newly granted stock options (exercise price $140.54) will become exercisable. |
| 02/26/2029 | Expiration date for stock options with an exercise price of $49.01. |
| 02/25/2030 | Expiration date for stock options with an exercise price of $55.27. |
| 02/23/2031 | Expiration date for stock options with an exercise price of $51.87. |
| 02/23/2032 | Expiration date for stock options with an exercise price of $69.41. |
| 02/28/2033 | Expiration date for stock options with an exercise price of $78.28. |
| 02/27/2034 | Expiration date for stock options with an exercise price of $95.74. |
| 02/25/2035 | Expiration date for stock options with an exercise price of $116.41. |
| 02/24/2036 | Expiration date for stock options with an exercise price of $140.54. |
Recommendation
holdThe filing details a routine grant of stock options to a key executive, which is a standard component of executive compensation and aligns management's interests with shareholders. However, it does not contain information significant enough to alter an investment thesis based solely on this disclosure, warranting a 'hold' recommendation.
Keywords
Hartford Insurance Group, HIG, Beth Ann Costello, Form 4, Insider Transaction, Stock Options, Executive Compensation, Beneficial Ownership, Insurance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.